2,5-Dichlorobenzamide - CAS 5980-26-7
Catalog: |
BB030506 |
Product Name: |
2,5-Dichlorobenzamide |
CAS: |
5980-26-7 |
Synonyms: |
2,5-dichlorobenzamide; 2,5-dichlorobenzamide |
IUPAC Name: | 2,5-dichlorobenzamide |
Description: | 2,5-Dichlorobenzamide (CAS# 5980-26-7) is a useful research chemical. |
Molecular Weight: | 190.03 |
Molecular Formula: | C7H5Cl2NO |
Canonical SMILES: | C1=CC(=C(C=C1Cl)C(=O)N)Cl |
InChI: | InChI=1S/C7H5Cl2NO/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3H,(H2,10,11) |
InChI Key: | NMHJIYQWKWHDSX-UHFFFAOYSA-N |
Boiling Point: | 262.8 ℃ at 760 mmHg |
Density: | 1.439 g/cm3 |
Appearance: | Powder |
LogP: | 2.79260 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021054344-A1 | Cpc exosomes mirna373 combination therapies | 20180126 |
TW-201930264-A | Immunoproteasome inhibitor | 20171116 |
JP-2021503467-A | Immune proteasome inhibitor | 20171116 |
JP-2021503471-A | Immune proteasome inhibitor | 20171116 |
TW-201837046-A | Process for prepararing intermediate compound of ixazomib citrate, and ixazomib citrate made thereby | 20170414 |
Complexity: | 163 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 188.9748192 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 188.9748192 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 43.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS